RVX Share Price

Open 1.38 Change Price %
High 1.38 1 Day -0.05 -3.70
Low 1.30 1 Week -0.09 -6.47
Close 1.30 1 Month -0.76 -36.89
Volume 217663 1 Year 0.10 8.33
52 Week High 2.47
52 Week Low 1.10
RVX Important Levels
Resistance 2 1.37
Resistance 1 1.34
Pivot 1.33
Support 1 1.26
Support 2 1.23
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
BBD-B 2.39 -3.63%
HCG 19.00 27.18%
HCG 19.00 27.18%
HCG 19.00 27.18%
HCG 19.00 27.18%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
HE 0.04 100.00%
HE 0.04 100.00%
TVI 0.02 100.00%
LRT-UN 0.04 100.00%
HCG 19.00 27.18%
HCG 19.00 27.18%
HCG 19.00 27.18%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
DNT 0.06 -14.29%
BLU 0.36 -12.20%
GGA 0.08 -11.11%
CTU-A 0.19 -9.52%
DEJ 0.14 -6.67%
DEJ 0.14 -6.67%
BU 1.45 -6.45%
GEN 0.15 -6.25%
GEN 0.15 -6.25%
More..

Resverlogix Corp (TSE: RVX)

RVX Technical Analysis 5
As on 22nd Jun 2017 RVX Share Price closed @ 1.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.81 & Strong Sell for SHORT-TERM with Stoploss of 1.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
RVX Target for June
1st Target up-side 2.28
2nd Target up-side 2.4
3rd Target up-side 2.51
1st Target down-side 1.96
2nd Target down-side 1.84
3rd Target down-side 1.73
RVX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.resverlogix.com
RVX Address
RVX
279 Midpark Way S.E.
Suite 202
Calgary, AB T2X 1M2
Canada
Phone: 403-254-9252
Fax: 403-256-8495
RVX Latest News
Resverlogix Comments on TSX Trader Notes   Canada NewsWire (press release)   - 21st Jun 17
BRIEF-Eastern Capital Ltd acquires additional shares and warrants of ...   Reuters   - 21st Jun 17
Eastern Capital Limited Acquires Additional Shares and Warrants of Resverlogix ...   Canada NewsWire (press release)   - 21st Jun 17
Resverlogix Closes $10 Million of Equity Subscriptions   Canada NewsWire (press release)   - 20th Jun 17
IIROC Trade Resumption - Resverlogix Corp.   Stockhouse   - 20th Jun 17
FY2017 EPS Estimates for Resverlogix Corp. Increased by Zacks Investment ...   The Cerbat Gem   - 17th Jun 17
Resverlogix: The Science Is Getting 'BETter' For RVX208   Seeking Alpha   - 27th Feb 17
Resverlogix Highlights Unique Properties of Apabetalone in Both a Rare ...   Canada NewsWire (press release)   - 13th Feb 17
Resverlogix: Analysis Of The Science Behind RVX-208   Seeking Alpha   - 08th Apr 15
0.9643   MarketWatch   - 21st Apr 11
Interactive Technical Analysis Chart Resverlogix Corp ( RVX TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Resverlogix Corp
RVX Business Profile
Resverlogix Corp., a clinical stage cardiovascular company, develops compounds, which include a therapeutic increase in Apolipoprotein A-I. It primarily develops RVX-208, a small molecule that has completed a Phase IIb clinical trial SUSTAIN and is undergoing a second Phase IIb trial ASSURE for the treatment of atherosclerosis and other chronic diseases, such as neurodegenerative disorders, diabetes mellitus, and Alzheimer's disease. The company is headquartered in Calgary, Canada.